Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Q3 2025 value amounting to 1.48.

  • Ironwood Pharmaceuticals' Debt Ratio rose 4371.25% to 1.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.48, marking a year-over-year increase of 4371.25%. This contributed to the annual value of 1.1 for FY2024, which is 345.89% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Debt Ratio stood at 1.48 for Q3 2025, which was up 4371.25% from 1.7 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Debt Ratio ranged from a high of 1.7 in Q2 2025 and a low of 0.1 during Q4 2021
  • Over the past 5 years, Ironwood Pharmaceuticals' median Debt Ratio value was 1.04 (recorded in 2024), while the average stood at 0.87.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Debt Ratio surged by 264.02% in 2024 and then soared by 5860.73% in 2025.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Debt Ratio stood at 0.1 in 2021, then rose by 7.33% to 0.11 in 2022, then skyrocketed by 852.8% to 1.06 in 2023, then grew by 3.46% to 1.1 in 2024, then surged by 34.51% to 1.48 in 2025.
  • Its Debt Ratio stands at 1.48 for Q3 2025, versus 1.7 for Q2 2025 and 1.18 for Q1 2025.